Linda Rebrovick, serving as a director at HEALTHSTREAM INC (NASDAQ:HSTM), offloaded a significant block of the company's common stock, with total transaction values reaching $174,000. This activity was documented in a recent regulatory filing, detailing the disposal of 6,000 shares executed on July 6, 2026. The shares were divested at a price of $29.00 per share.
Following this transaction, Ms. Rebrovick's direct holdings in HealthStream common stock stand at 51,329 shares. The sale takes place against a backdrop of robust stock performance, with shares trading near their 52-week high of $29.62. Over the course of the year, the stock has appreciated by 26% year-to-date.
According to analysis from InvestingPro, HealthStream's current valuation appears elevated relative to its calculated Fair Value. This assessment places the company among those identified on the "Most Overvalued" list. The transaction itself was facilitated under a Rule 10b5-1 trading plan, a pre-arranged framework designed to allow insiders to trade stock during periods when they might otherwise be restricted. Ms. Rebrovick originally adopted this plan on November 21, 2025.
In broader corporate developments, HealthStream Inc. recently reported its financial results for the first quarter of 2026. The company's performance surpassed analyst expectations, recording an earnings per share (EPS) of $0.20. This figure represents a significant 17.65% surprise above the anticipated $0.17.
Revenue metrics also outpaced forecasts, with HealthStream achieving $81.2 million compared to the expected $79.68 million. These results underscore the company's strong operational performance during the period. However, despite these positive financial indicators, investor apprehension regarding future guidance and prevailing market conditions has been noted. This sentiment was reflected in the stock's premarket decline, highlighting ongoing concerns among market participants.